학술논문

OA20.01 Tumor Mutation Burden (TMB) is Associated with Improved Efficacy of Atezolizumab in 1L and 2L+ NSCLC Patients
Document Type
Abstract
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S321-S322
Subject
Language
ISSN
1556-0864